Google
AKAN — AKANDA CORP (Healthcare >> Drug Manufacturers - Specialty & Generic)
AKAN FAQ
What is AKAN's ROE?
AKANDA CORP reports a Return on Equity (ROE) of -948.39%.
What is AKAN's dividend yield?
AKANDA CORP offers a dividend yield of 0.00%.
What is AKAN's Deepscope Quality Score?
Deepscope rates AKAN's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy AKAN?
Deepscope's AI Timing Score for AKAN is 66 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does AKAN belong to?
AKANDA CORP is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.
|
USD 16.49
Price
-0.61
(-3.57%)
Day Change
|
|
|---|
AKAN, the overall quality is not good ( Quality = 38) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROE is decreasing significantly
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
44% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 85 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 16.49 |
| PBV / Sector |
2.63 / 2.65
|
| Earning Per Share | -59.52 |
| PE / Sector |
N/A / 22.64
|
| PEG or PE/Growth / Sector |
N/A / 0.11
|
| Average 1M Daily Value |
16.87 M
GREAT
|
| Average 1W Daily Value |
1.78 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
52% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-04 09:23:57 |
| Symbol | AKAN |
| Name | AKANDA CORP |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 0.53 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 8.67 / 9,480.84 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 100 King St. W, Toronto, ON, Canada, M5X 1G5
Phone: 416 862 7525
Website: https://www.akandacorp.com
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: As of August 21, 2025, Akanda Corp. was acquired by First Towers & Fiber Corp., in a reverse merger transaction. Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products. The company was incorporated in 2021 and is headquartered in Toronto, Canada.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
